Heron Therapeutics, Inc. (NASDAQ:HRTX) Q2 2023 Earnings Call Transcript August 14, 2023
Heron Therapeutics, Inc. misses on earnings expectations. Reported EPS is $-0.35 EPS, expectations were $0.23.
Operator: Good day, ladies and gentlemen, and thank you for standing by. Welcome to the Heron Therapeutics Second Quarter 2023 Earnings Conference Call. As a reminder, this conference is being recorded. Now, I would like to turn the call over to Jeff Cohen, Executive Director, Assistant General...
